rethinkPeptides Search
Menu
Research citation

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

evidence

This record provides bibliographic details and links to the original research. An editorial study breakdown is not available.

Read the original research

Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.

Menopause (New York, N.Y.), 27(10), 1137-1142

Citation

Greenspan, Susan L; Fitzpatrick, Lorraine A; Mitlak, Bruce; Wang, Yamei; Harvey, Nicholas C; Deal, Chad; Cosman, Felicia; McClung, Michael. (2020). Abaloparatide followed by alendronate in women ≥80 years with osteoporosis: post hoc analysis of ACTIVExtend.. Menopause (New York, N.Y.), 27(10), 1137-1142. https://doi.org/10.1097/GME.0000000000001593